The WHO PIDM in Focus - Vaccine Safety

Since 1978, UMC has worked closely with the WHO and their Programme for International Drug Monitoring (WHO PIDM) to help monitor the safety of medicines and vaccines worldwide.
The COVID-19 pandemic led to an increased focus on strengthening vaccine surveillance systems globally. UMC, under the guidance of WHO, has worked with WHO PIDM member countries to support them with training, tools and guidance on how to improve their systems, by collecting and analysing AEFI (Adverse event following immunisation) reports.
This film looks at why vaccine surveillance is so important, the challenges posed by COVID-19 and what UMC has done within the WHO PIDM to develop and improve vaccine safety.
For more information on UMC's work with vaccine safety, please visit our website - who-umc.org/pv-products/vigiflow-for-aefi/